Evidence map›Paper›PMID 40832633›Full record

ArticleFrontiers in nutrition2025

The improvement effect of insoluble dietary fiber of

Yanli Ma, Jingxuan Ke, Yuan Wang, Yuhui Zhou, Xinyu Gao, Xin Wang, Qingshan Shen

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanli Ma *Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology, Nanyang, China.
Jingxuan Ke *Zhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology, Nanyang, China.
Yuan WangZhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology, Nanyang, China.
Yuhui ZhouZhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology, Nanyang, China.
Xinyu GaoZhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology, Nanyang, China.
Xin WangCollege of Food Science and Technology, Hebei Agricultural University, Baoding, China.
Qingshan ShenZhang Zhongjing School of Chinese Medicine, Nanyang Institute of Technology, Nanyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: Male C57BL/6 J mice were fed with a high-fat diet continuously for 8 weeks. At the same time, the low-dose and high-dose groups were supplemented with 0.5 g/kg·BW and 1.0 g/kg·BW of PIDF, respectively. The weight and food intake of the mice were measured during the experiment. After 8 weeks of feeding, the organ weight, serum indexes, and liver function were investigated. Furthermore, the mechanism of antihyperlipidemic was explained by analyzing the gut microbiota and metabolites. Results: The results of the LIDF and HIDF showed that the PIDF treatment significantly alleviated the liver and kidney weight and body fat index. PIDF administration remarkably increased the high-density lipoprotein cholesterol level and enhanced hepatic superoxide dismutase activity in high-fat diet-fed mice. The levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, glucose, and aspartate transaminase in the HIDF were significantly lower than in the high-fat diet group. In addition, PIDF supplements also decreased the ratio of Conclusion: It can be concluded that PIDF may alleviate hyperlipidemia by regulating cholesterol metabolism, increasing the abundance of beneficial microorganisms, and controlling its metabolites. The results of this study accelerated the application of PIDF in the health food industry.

Indexed as

antihyperlipidemic effectgut microbiomeinsoluble dietary fibermetabolite profilePolygonatum sibiricum

Identifiers

PMID40832633
PMCPMC12358496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.